Diabetes News and Research

Latest Diabetes News and Research

UMCG enrolls and treats first patients in RENEW pivotal trial to evaluate RePneu LVRC

PneumRx, Inc., a leader in interventional pulmonology, announced today that University Medical Center Groningen has enrolled and treated the first patients in the FDA-approved RENEW pivotal trial to evaluate the RePneu Lung Volume Reduction Coil.

17 Dec 2012

Dyslipidaemia: an interview with Prof. Peter Kokkinos

Dyslipidemia is defined as abnormal levels of blood lipids (fats) and cholesterol. The most common dyslipidaemias are high blood cholesterol (Total Cholesterol) and triglyceride levels, high levels of low-density lipoprotein (LDL) cholesterol (‘bad’ cholesterol) and low levels of high-density lipoprotein (HDL) cholesterol (‘good’ cholesterol).

17 Dec 2012

Apophysomyces fungus kills 5 people following a massive Joplin tornado

A fast growing, flesh-eating fungus killed 5 people following a massive tornado that devastated Joplin, Mo., according to two new studies based on genomic sequencing by the Translational Genomics Research Institute (TGen) and the U.S. Centers for Disease Control and Prevention (CDC).

16 Dec 2012

Americans are concerned about impact of spending cuts to medical research, poll reveals

Nearly 60% of Americans are skeptical that Congress and the White House will reach an agreement that will avoid the fiscal cliff, according to a new national public opinion poll commissioned by Research!America.

15 Dec 2012

Genesee Health Plan joins Disparities and Cardiac Health Program initiative

MPRO, Michigan's Quality Improvement Organization, announced that Genesee Health Plan is joining its Disparities and Cardiac Health Program, a special project headed by the Centers for Medicare & Medicaid Services.

15 Dec 2012

Aerobic training the best mode of exercise for burning fat

Aerobic training is the best mode of exercise for burning fat, according to Duke researchers who compared aerobic training, resistance training, and a combination of the two.

15 Dec 2012

Novartis receives FDA approval for Signifor injection to treat Cushing's disease

The U.S. Food and Drug Administration today approved Signifor (pasireotide diaspartate) injection for the treatment of Cushing's disease patients who cannot be helped through surgery.

15 Dec 2012

Global Burden of Disease Study finds people worldwide living longer, but with more illness, disability

"A sharp decline in deaths from malnutrition and infectious diseases like measles and tuberculosis has caused a shift in global mortality patterns over the past 20 years, according to a study released on Thursday, with far more of the world's population now living into old age and dying from diseases mostly associated with rich countries, like cancer and heart disease," the New York Times reports.

15 Dec 2012

Consuming whole eggs may improve blood lipids, new research suggests

It is estimated that 34% of Americans are affected by an increasingly prevalent condition known as metabolic syndrome which is a combination of at least three of the following risk factors: large waistline, high triglycerides, low HDL cholesterol, high blood pressure and elevated blood sugar.

15 Dec 2012

Paroxetine could treat vascular complications of diabetes

University of Texas Medical Branch at Galveston researchers have discovered that the commonly used antidepressant drug paroxetine could also become a therapy for the vascular complications of diabetes.

14 Dec 2012

Scientists discover how Yersinia pestis avoids setting off immune system's early infection-alarm

The plague-causing bacteria Yersinia pestis evades detection and establishes a stronghold without setting off the body's early alarms.

14 Dec 2012

FDA approves Novartis Signifor injection for treatment of Cushing's disease

Novartis announced today that the US Food and Drug Administration (FDA) has approved Signifor (pasireotide) injection for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative.

14 Dec 2012

God will control my asthma

Research shows that patients’ belief in God influences how likely they are to be adherent to asthma medication.

14 Dec 2012

Diabetes risk increased in relatives of schizophrenia patients

The prevalence of diabetes is increased in the unaffected relatives of patients with non-affective psychosis, results from a Dutch study show.

14 Dec 2012

Visual impairment and diabetes increase side by side

Visual impairment that is not explained by refractive error is increasing, as is the prevalence of diabetes – particularly diabetes lasting 10 years or longer, show US study results.

14 Dec 2012

Concern over enoxaparin bleeding risk in patients with moderate renal impairment

The low molecular weight heparin enoxaparin is associated with an increased risk for major bleeding in patients who have moderate renal impairment, say US scientists in findings that have prompted calls for updates to dosing recommendations.

14 Dec 2012

Definitions, responsibilities are crucial to medication reconciliation

To implement effective medication reconciliation, a definition of what the term means, as well as identification of who is responsible for the process, is necessary, show the results of a focus group-based study.

14 Dec 2012

High-risk leukemia patients respond to novel drug

A third of adult leukemia patients given the novel drug quizartinib during a phase II study have achieved a composite response of either complete remission, or remission with incomplete platelet recovery or incomplete hematologic recovery, report US researchers.

14 Dec 2012

Australian researchers to establish dedicated asthma service for pregnant women

Researchers in Australia will establish the world's first dedicated asthma service for pregnant women in a trial of what they hope will reduce the adverse effects of asthma on the growth and survival of babies.

14 Dec 2012

IOF kicks off 3rd Asia-Pacific Osteoporosis Meeting

Doctors and researchers from across the Asia-Pacific gathered today for the opening of the International Osteoporosis Foundation's (IOF) 3rd Asia-Pacific Osteoporosis Meeting, taking place at the Kuala Lumpur Convention Centre until December 16, 2012.

14 Dec 2012

Diabetes News and Research

Latest Diabetes News and Research

UMCG enrolls and treats first patients in RENEW pivotal trial to evaluate RePneu LVRC

Dyslipidaemia: an interview with Prof. Peter Kokkinos

Apophysomyces fungus kills 5 people following a massive Joplin tornado

Americans are concerned about impact of spending cuts to medical research, poll reveals

Genesee Health Plan joins Disparities and Cardiac Health Program initiative

Aerobic training the best mode of exercise for burning fat

Novartis receives FDA approval for Signifor injection to treat Cushing's disease

Global Burden of Disease Study finds people worldwide living longer, but with more illness, disability

Consuming whole eggs may improve blood lipids, new research suggests

Paroxetine could treat vascular complications of diabetes

Scientists discover how Yersinia pestis avoids setting off immune system's early infection-alarm

FDA approves Novartis Signifor injection for treatment of Cushing's disease

God will control my asthma

Diabetes risk increased in relatives of schizophrenia patients

Visual impairment and diabetes increase side by side

Concern over enoxaparin bleeding risk in patients with moderate renal impairment

Definitions, responsibilities are crucial to medication reconciliation

High-risk leukemia patients respond to novel drug

Australian researchers to establish dedicated asthma service for pregnant women

IOF kicks off 3rd Asia-Pacific Osteoporosis Meeting

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in